首页> 外文期刊>Antiviral Research >A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies
【24h】

A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies

机译:一种新型双抗原夹心ELISA,用于独立于克里米尔 - 刚果出血热病毒特异性抗体的物种检测

获取原文
获取原文并翻译 | 示例
           

摘要

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease in humans caused by the CCHF virus (CCHFV). The detection of anti-CCHFV antibodies in animals is used to reveal infection risk areas. Therefore a simple, quick and reliable multispecies assay for the detection of CCHFV-specific antibodies is needed. This work presents the development and validation of a novel CCHF double-antigen ELISA for the detection of anti-CCHFV nucleoprotein antibodies. The test requires 30 mu l of serum, and results are obtained within 90 min. As the ELISA is based on recombinant N-protein of the IbAr10200 virus, it can be run under standard biosafety conditions. For assay validation, sera from 95 cattle and 176 small ruminants from CCHF-endemic regions (origin: Albania, Cameroon, Kosovo, Former Yugoslav Republic of Macedonia, Mauritania, Pakistan, Turkey) served as a positive reference serum panel. The CCHF antibody status of the positive reference samples had been previously confirmed by two serological assays (species-adapted VectorBest ELISA and Euroimmun IFA). CCHFV strains belonging to three different clades are known to circulate in the countries where the positive samples originated. Sera from 402 cattle and 804 small ruminants from Germany and France served as the negative serum panel, as both countries are considered outside of the CCHFV endemic zone. Sera from monkeys, camels, rats, ferrets, raccoon dogs, raccoons, foxes, hares, pigs and humans were also tested, to determine the suitability of this novel ELISA for these species. All negative reference sera were confirmed by the CCHF double-antigen ELISA, indicating a specificity of 100%. 268 of 271 positive reference sera tested positive for CCHFV-specific antibodies, 8sensitivity of 99%9. Further analysis are needed to ensure a recognition of the IbAr10200 nucleoprotein by antibodies directed against all known CCHFV clades. This is planned to be realized with sera from other regions covering the three missing clades.
机译:克里米亚 - 刚果出血热(CCHF)是由CCHF病毒(CCHFV)引起的人类蜱型疾病。检测动物中的抗CCHFV抗体用于揭示感染风险区域。因此,需要一种用于检测CCHFV特异性抗体的简单,快速可靠的多层测定。这项工作提出了一种用于检测抗CCHFV核蛋白抗体的新型CCHF双抗原ELISA的开发和验证。测试需要30μl血清,并在90分钟内得到结果。由于ELISA基于IBAR10200病毒的重组N-蛋白,可以在标准生物安全条件下运行。对于测定验证,来自95个牛和176名来自CCHF-Difemocions的血清(起源:阿尔巴尼亚,喀麦隆,科索沃,前南斯拉夫共和国,前南斯拉夫,火鸡,毛里塔尼亚,巴基斯坦,土耳其)作为阳性参考血清面板。先前通过两种血清学测量(种适应的卷曲肌肌和Euroimmun IFA)证实了正面参考样品的CCHF抗体状态。众所周知,属于三种不同的曲线的CCHFV菌株在阳性样品起源的国家中循环。来自德国和法国的402次牛和804名小型反刍动物的血清作为负血清面板,因为这两个国家都被认为是CCHFV流行区之外。还测试了来自猴子,骆驼,大鼠,雪貂,浣熊,浣熊,狐狸,猪,猪和人类的血清,以确定这部新型ELISA对这些物种的适用性。所有阴性参考血清由CCHF双抗原ELISA确认,表明特异性为100%。 268个271个阳性参考血清测试CCHFV特异性抗体阳性,8次为99%9。需要进一步分析以确保通过针对所有已知的CCHFV片材的抗体识别IBar10200核蛋白。计划用来自其他地区的血清实现,覆盖着三个缺失的片断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号